Delve into the intricate intersections of competition law within the life sciences sector. This resource offers expert insights and practical guidance to help you navigate regulatory challenges and maintain compliance. Stay ahead of developments in anti-competitive practices, merger controls, and market regulations impacting pharmaceuticals, biotechnology, and medical devices. Equip yourself with the essential tools to support your clients in thriving within a highly regulated environment.
The European Medicines Agency (EMA) and the Heads of Medicines Agencies have published revision 2 of Module III of their good pharmacovigilance...
The European Medicines Agency (EMA) has published guidance on submitting electronic product information (ePI) for centrally authorised medicines...
The Medicines and Healthcare products Regulatory Agency (MHRA) has published the National Commission into the Regulation of AI in Healthcare’s...
This week's edition of Life Sciences weekly highlights includes an analysis of the request for a preliminary ruling in Case C-371/26 in the context of...
Introduction to technology transfer agreements in the Life Sciences industryWhat is a technology transfer agreement?The term ‘technology transfer...
Regulation of cosmetic products in the UKThis Practice Note provides an overview of the UK regulatory framework for cosmetics. It sets out the legal...
Intellectual property protection for medical devicesChanges to intellectual property (IP) law from 1 January 2021Before discussing how intellectual...
Second and subsequent medical use patent claimsBackground to medical use claimsSecond (and subsequent) medical use patent claims are specific to the...
If a rentcharge is shown as being informally exonerated on title information, does this apply to the current registered owner? Or does the informal exoneration only apply to the parties to the document which informally exonerated the rentcharge?This Q&A considers the situation where, at some point
Can shares in a limited company that have not been paid-up at all be cancelled?A limited company having a share capital may not alter that share capital, except in the ways listed in section 617 of the Companies Act 2006 (CA 2006). Shares in a company cannot simply be cancelled without following an
Glossary—Latin legal termsDespite attempts in recent years to simplify the language used in legal cases, there are still a number of Latin phrases commonly used in personal injury claims. The following Latin phrases are listed in alphabetical order:Latin termDefinitionMeaningActa iure imperiiLegal
Template for regulatory references given by SMCR firms and disclosure requirements[Insert addressee details]Dear [insert name][It is our understanding that [insert name of prospective employee] [was an employee of yours between the dates of [insert dates as appropriate] OR is a current employee of
0330 161 1234